8-K 1 s620693.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 17, 2002 FISHER SCIENTIFIC INTERNATIONAL INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-10920 02-0451017 (Commission File No.) (IRS Employer Identification No.) One Liberty Lane, Hampton, New Hampshire 03842 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (603) 926-5911 Not Applicable (Former name or former address, if changed since last report) Item 5. Other Events. Fisher Scientific International Inc. (the "Company") issued a press release announcing the offering of $150 million principal amount 8 1/8% senior subordinated notes due 2012 in a private offering pursuant to Rule 144A of the Securities Act of 1933, and outside the United States pursuant to Regulation S under the Securities Act. A copy of the press release is filed as an exhibit hereto and is incorporated as a reference herein. Item 7. Financial Statements and Exhibits. (c) The following document is filed as an exhibit hereto: 99.1 Press Release issued by the Company, dated April 17, 2002. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FISHER SCIENTIFIC INTERNATIONAL INC. By: /s/ Kevin P. Clark ------------------------------ Name: Kevin P. Clark Title: Vice President and Chief Financial Officer Date: April 23, 2002 EXHIBIT INDEX Designation Description 99.1 Press Release issued by the Company, dated April 17, 2002.